Pura Vida Investments’s Adverum Biotechnologies ADVM Stock Holding History

Pura Vida Investments’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-10,000	Closed	-$545K	–	101
2019 Q3	$545K	Buy	+10,000	New	+$1.13M	0.09%	88

Other funds holding ADVM

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Kam Lawrence $97.4M AUM

SFI

Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pura Vida Investments's ADVM Position: Q4 2019 in Review

Pura Vida Investments sold out of Adverum Biotechnologies (ADVM) in Q4 2019, closing a stake of 10,000 shares — an estimated $545K sold.

Pura Vida Investments first reported a position in ADVM in Q3 2019 and held it in 1 quarter. The position peaked at $545K in Q3 2019. 116 funds tracked by Wall St. Rank hold ADVM as of Q4 2019.

Pura Vida Investments reported no remaining Adverum Biotechnologies position as of Q4 2019 after selling out during the quarter.
Pura Vida Investments sold 10,000 Adverum Biotechnologies shares in Q4 2019, an estimated $545K.
Pura Vida Investments first reported a position in Adverum Biotechnologies in Q3 2019 and held it in 1 quarter.
Pura Vida Investments's Adverum Biotechnologies position peaked at $545K in Q3 2019.
116 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2019.

Based on Pura Vida Investments's 13F filing for Q4 2019, filed 14 Feb 2020.